$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 3, 2025)
$29.44M
Market Cap
-
P/E Ratio
-0.79
EPS
$10.84
52 Week High
$1.75
52 Week Low
INDUSTRIALS
Sector
Sector: INDUSTRIALS
Industry: POLLUTION & TREATMENT CONTROLS
Rain Enhancement Technologies Holdco, Inc. is a clinical-stage precision oncology firm headquartered in Newark, California, focused on developing cutting-edge therapies that specifically target oncogenic drivers in cancer treatment. The company boasts a promising pipeline of innovative therapeutic candidates, utilizing advanced research methodologies and clinical insights to optimize patient outcomes. By addressing critical unmet needs in oncology, Rain Therapeutics is well-positioned to leverage the growing demand for targeted therapies in the evolving biopharmaceutical landscape, appealing to institutional investors seeking opportunities in the oncology sector.
LPTX
VRAX
IRBT
VHAI
NVDA
IPG
NIO
PLUG
TSLA
ADAP
ASST
MARA
BITF
BYND
INTC
CAPR
RR
IREN
VALE
MRVL
NFLX
AAL
MTSR
PFE
HOOD
DNN
SOFI
PMAX
F
HTOO
CIFR
MSFT
QBTS
CCL
AMD
ASBP
GOOGL
PLTD
PLTR
AMC
AEO
CLSK
PYPL
BTBT
RIG
KDLY
CMG
CSCO
WULF
SAND
M
SHOT
GTLB
ZAPP
DVLT
BMY
NOK
MSTR
HBAN
GRAB
SU
HIMS
PINS
PSTG
ALIT
RGTI
LPTX
VRAX
IRBT
VHAI
NVDA
IPG
NIO
PLUG
TSLA
ADAP
ASST
MARA
BITF
BYND
INTC
CAPR
RR
IREN
VALE
MRVL
NFLX
AAL
MTSR
PFE
HOOD
DNN
SOFI
PMAX
F
HTOO
CIFR
MSFT
QBTS
CCL
AMD
ASBP
GOOGL
PLTD
PLTR
AMC
AEO
CLSK
PYPL
BTBT
RIG
KDLY
CMG
CSCO
WULF
SAND
M
SHOT
GTLB
ZAPP
DVLT
BMY
NOK
MSTR
HBAN
GRAB
SU
HIMS
PINS
PSTG
ALIT
RGTI